Any idea why there was so much excitement as evidenced by the price/volume action when the trials were initially approved by the FDA but now that they're about to begin, no one seems to care based on the current price/volume action?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.